SCHEMBL948140

SCHEMBL948140

Cc1nc(C2CCN(C(=O)OC(C)(C)C)CC2)n(C)c1C

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.50
KDM4E B2RXH2 1/20 0.50
THRB P10828 1/20 0.50
GPR119 Q8TDV5 7/20 0.44
PIK3CD O00329 1/20 0.44
HPGD P15428 1/20 0.44
HTT P42858 2/20 0.43
TRPV3 Q8NET8 1/20 0.43
RECQL P46063 1/20 0.42
EPHX1 P07099 1/20 0.42
HPGDS O60760 1/20 0.42
NPC1 O15118 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPK1 P28482 1/20 0.42
RAB9A P51151 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PTPN2 P17706 1/20 0.41
PTPN1 P18031 1/20 0.41
PTPN6 P29350 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL948728 0.85 THRB (0.48) MAPTKDM4ETHRBGPR119PIK3CD
SCHEMBL17001900 0.81 MAPT (0.49) MAPTKDM4ETHRBGPR119HPGD
SCHEMBL786081 0.78 P2RY14 (0.50) MAPTGPR119HTTPTPN2PTPN1
SCHEMBL3779989 0.77 HTR2B (0.61) MAPTKDM4ETHRBGPR119HPGDS
SCHEMBL15732648 0.77 TP53 (0.49) GPR119HPGDS
SCHEMBL17712708 0.76 THRB (0.47) MAPTKDM4ETHRBGPR119HPGD
SCHEMBL949709 0.76 FAAH (0.45) MAPTKDM4ETHRBGPR119PTPN2
SCHEMBL15891183 0.75 THRB (0.46) MAPTKDM4ETHRBGPR119HPGD
SCHEMBL3262079 0.75 KDM4E (0.49) MAPTKDM4ETHRBGPR119HPGD
SCHEMBL15732697 0.75 GPR119 (0.47) MAPTGPR119HPGDS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009389-A1 IMIDAZOLE DERIVATIVE, THEIR PRODUCTION AND USE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
US-20070004736-A1 Imidazole derivative, process for producing the same, and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-01-04 US disclosed
EP-1564213-A1 IMIDAZOLE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE Takeda Pharmaceutical Company Limited (JP) 2005-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004736-A1 Imidazole derivative, process for producing the same, and use HRH4, F2, HRH2 MAPT 4771/4885KDM4E 1356/4885THRB 615/4885
US-20110009389-A1 IMIDAZOLE DERIVATIVE, THEIR PRODUCTION AND USE F2, H1-3, CYC1 MAPT 4800/4885KDM4E 1558/4885THRB 604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.